1. Gilead Sciences Refuses Direct Sale of HIV Prevention Drug to Doctors Without Borders, Sparking 'Unconscionable' Criticism
Doctors Without Borders has launched a sharp public rebuke of Gilead Sciences, labeling the pharmaceutical giant's refusal to sell a groundbreaking HIV prevention drug directly to humanitarian organizations as 'unconscionable.' The criticism centers on lenacapavir, a long-acting injectable that offers virtually complet...